Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) will host a live audio webcast at the UBS Global Healthcare Conference. Eyal Desheh, EVP & CFO will present on Monday, May 19, 2014 at 1:00 PM ET.
Teva Presentation at the UBS Global Healthcare Conference
Eyal Desheh, EVP and CFO,
Teva Pharmaceutical Industries Ltd.
Monday, May 19, 2014
Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s website.
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) is a leading global pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients. Headquartered in Israel, Teva is the world's leading generic drug maker, with a global product portfolio of more than 1,000 molecules and a direct presence in approximately 60 countries. Teva's Specialty Medicines businesses focus on CNS, respiratory oncology, pain, and women's health therapeutic areas as well as biologics. Teva currently employs approximately 45,000 people around the world and reached $20.3 billion in net revenues in 2013.